Electrophysiological remodeling in hypertrophy and heart failure

Cardiovascular Research

Volumn 42, Issue 2, 1999, Pages 270-283

  Tomaselli, Gordon F ^a   Marbán, Eduardo ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM; DEOXYCORTICOSTERONE ACETATE; GROWTH HORMONE; ION CHANNEL; MESSENGER RNA; POTASSIUM; REGULATOR PROTEIN;

ARRHYTHMOGENESIS; CALCIUM CURRENT; CALCIUM HOMEOSTASIS; DOWN REGULATION; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE REMODELING; HUMAN; ION TRANSPORT; NONHUMAN; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; REVIEW;

ACTION POTENTIALS; ANIMALS; ARRHYTHMIA; BIOLOGICAL TRANSPORT, ACTIVE; CALCIUM; CARDIOMEGALY; DOGS; GUINEA PIGS; HEART FAILURE, CONGESTIVE; HUMANS; ION CHANNELS; ION TRANSPORT; MYOCARDIUM; NA(+)-K(+)-EXCHANGING ATPASE; RABBITS; RATS;

EID: 0032979720     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00017-6     Document Type: Review

References (171)

1. Anonymous. Changes in mortality from heart failure - United States, 1980-1995. Morbidity Mortality Week. Rep. 1998;47:633-637.
2. Konstam M.A., Remme W.J. Treatment guidelines in heart failure. Prog Cardiovasc Dis. 48:1998;65-72.
3. Kjekshus J. Arrhythmias and mortality in congestive heart failure. Am J Cardiol. 65:1990;42I-48I.
4. Chakko C.S., Gheorghiade M. Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy. Am Heart J. 109:1985;497-504.
5. Wilson J.R., Schwartz J.S., Sutton M.S., et al. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol. 2:1983;403-410.
6. von Olshausen K., Schafer A., Mehmel H.C., Schwarz F., Senges J., Kubler W. Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J. 51:1984;195-201.
7. Califf R.M., McKinnis R.A., Burks J., et al. Prognostic implications of ventricular arrhythmias during 24 h ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery disease. Am J Cardiol. 50:1982;23-31.
8. Cohn J.N., Archibald D.G., Ziesche S., et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. New Engl J Med. 314:1986;1547-1552.
9. Bassett A.L., Gelband H. Chronic partial occlusion of the pulmonary artery in cats. Change in ventricular action potential configuration during early hypertrophy. Circ Res. 32:1973;15-26.
10. Benitah J.P., Gomez A.M., Bailly P., et al. Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts. J Physiol (Lond). 469:1993;111-138.
11. Brooksby P., Levi A.J., Jones J.V. The electrophysiological characteristics of hypertrophied ventricular myocytes from the spontaneously hypertensive rat. J Hypertens. 11:1993;611-622.
12. Bryant S.M., Shipsey S.J., Hart G. Regional differences in electrical and mechanical properties of myocytes from guinea-pig hearts with mild left ventricular hypertrophy. Cardiovas Res. 35:1997;315-323.
13. Cerbai E., Barbieri M., Li Q., Mugelli A. Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages. Cardiovasc Res. 28:1994;1180-1187.
14. Coulombe A., Momtaz A., Richer P., Swynghedauw B., Coraboeuf E. Reduction of calcium-independent transient outward potassium current density in DOCA salt hypertrophied rat ventricular myocytes. Pflügers Arch. 427:1994;47-55.
15. Keung E.C., Aronson R.S. Non-uniform electrophysiological properties and electrotonic interaction in hypertrophied rat myocardium. Circ Res. 49:1981;150-158.
16. Kleiman R.B., Houser S.R. Outward currents in normal and hypertrophied feline ventricular myocytes. Am J Physiol. 256:1989;H1450-H1461.
17. Li Q., Keung E.C. Effects of myocardial hypertrophy on transient outward current. Am J Physiol. 266:1994;H1738-H1745.
18. Gulch R.W. Alterations in excitation of mammalian myocardium as a function of chronic loading and their implications in the mechanical events. Basic Res Cardiol. 75:1980;73-80.
19. Nordin C., Siri F., Aronson R.S. Electrophysiologic characteristics of single myocytes isolated from hypertrophied guinea-pig hearts. J Mol Cell Cardiol. 21:1989;729-739.
20. Ryder K.O., Bryant S.M., Hart G. Membrane current changes in left ventricular myocytes isolated from guinea pigs after abdominal aortic coarctation. Cardiovasc Res. 27:1993;1278-1287.
21. Tomita F., Bassett A.L., Myerburg R.J., Kimura S. Diminished transient outward currents in rat hypertrophied ventricular myocytes. Circ Res. 75:1994;296-303.
22. Potreau D., Gomez J.P., Fares N. Depressed transient outward current in single hypertrophied cardiomyocytes isolated from the right ventricle of ferret heart. Cardiovasc Res. 30:1995;440-448.
23. + channel subunit mRNAs in ventricles of renovascular hypertensive rats. Circ Res. 81:1997;533-539.
24. Li G.R., Ferrier G.R., Howlett S.E. Calcium currents in ventricular myocytes of prehypertrophic cardiomyopathic hamsters. Am J Physiol. 268:1995;H999-H1005.
25. Thuringer D., Coulombe A., Deroubaix E., Coraboeuf E., Mercadier J.J. Depressed transient outward current density in ventricular myocytes from cardiomyopathic Syrian hamsters of different ages. J Mol Cell Cardiol. 28:1996;387-401.
26. Thuringer D., Deroubaix E., Coulombe A., Coraboeuf E., Mercadier J.J. Ionic basis of the action potential prolongation in ventricular myocytes from Syrian hamsters with dilated cardiomyopathy. Cardiovasc Res. 31:1996;747-757.
27. + current in ventricular myocytes from acromegalic rats. Am J Physiol. 260:1991;H935-H942.
28. max and the transient outward current. Circulation. 85:1992;1175-1188.
29. Qin D., Zhang Z.H., Caref E.B., Boutjdir M., Jain P., el-Sherif N. Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium. Circ Res. 79:1996;461-473.
30. Bril A., Forest M.C., Gout B. Ischemia and reperfusion-induced arrhythmias in rabbits with chronic heart failure. Am J Physiol. 261:1991;H301-H307.
31. + channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circ Res. 79:1996;669-675.
32. Kääb S., Nuss H.B., Chiamvimonvat N., et al. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res. 78:1996;262-273.
33. Rozanski G.J., Xu Z., Whitney R.T., Murakami H., Zucker I.H. Electrophysiology of rabbit ventricular myocytes following sustained rapid ventricular pacing. J Mol Cell Cardiol. 29:1997;721-732.
34. O'Rourke B., Kass D.A., Tomaselli G.F., Kääb S., Tunin R., Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure: 1 Experimental studies. Circ Res 1999;84:in press.
35. Coltart D.J., Meldrum S.J. Intracellular action potential in hypertrophic obstructive cardiomyopathy. Br Heart J. 34:1972;204.
36. Gwathmey J.K., Copelas L., MacKinnon R., et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 61:1987;70-76.
37. Vermeulen J.T., McGuire M.A., Opthof T., et al. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res. 28:1994;1547-1554.
38. Beuckelmann D.J., Näbauer M., Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 85:1992;1046-1055.
39. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res. 73:1993;379-385.
40. Pak P.H., Nuss H.B., Tunin R.S., et al. Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy. J Am Coll Cardiol. 30:1997;576-584.
41. Pye M.P., Cobbe S.M. Arrhythmogenesis in experimental models of heart failure: the role of increased load. Cardiovasc Res. 32:1996;248-257.
42. Litovsky S.H., Antzelevitch C. Rate dependence of action potential duration and refractoriness in canine ventricular endocardium differs from that of epicardium: role of the transient outward current. J Am Col Cardiol. 14:1989;1053-1066.
43. Fedida D., Giles W.R. Regional variations in action potentials and transient outward current in myocytes isolated from rabbit left ventricle. J Physiol (Lond). 442:1991;191-209.
44. Lukas A., Antzelevitch C. Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia. Role of the transient outward current. Circulation. 88:1993;2903-2915.
45. Drouin E., Charpentier F., Gauthier C., Laurent K., Le Marec H. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol. 26:1995;185-192.
46. to and action potential notch are smaller in left vs. right canine ventricular epicardium. Am J Physiol. 1996;271.
47. Barr C.S., Naas A., Freeman M., Lang C.C., Struthers A.D. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 343:1994;327-329.
48. Berger R.D., Kasper E.K., Baughman K.L., Marban E., Calkins H., Tomaselli G.F. Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation. 96:1997;1557-1565.
49. Furukawa T., Kimura S., Furukawa N., Bassett A.L., Myerburg R.J. Potassium rectifier currents differ in myocytes of endocardial and epicardial origin. Circ Res. 70:1992;91-103.
50. Ks contributes to the longer action potential of the M cell. Circ Res. 76:1995;351-365.
51. Ten Eick R.E., Zhang K., Harvey R.D., Bassett A.L. Enhanced functional expression of transient outward current in hypertrophied feline myocytes. Cardiovasc Drugs Ther. 3:1993;611-619.
52. Wettwer E., Amos G.J., Posival H., Ravens U. Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ Res. 75:1994;473-482.
53. Näbauer M., Beuckelmann D.J., Uberfuhr P., Steinbeck G. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation. 93:1996;168-177.
54. + channel currents in rat ventricular myocytes. J Gen Physiol. 108:1996;405-419.
55. + channel gene expression in rat ventricle. J Physiol (Lond). 504:1997;271-286.
56. Näbauer M., Barth A., Kääb S. A second calcium-independent transient outward current present in human left ventricular myocardium. Circulation. 1998;I-231.
57. + channel cloned from the rat cardiovascular system. FEBS Lett. 295:1991;211-213.
58. Po S., Snyders D.J., Baker R., Tamkun M.M., Bennett P.B. Functional expression of an inactivating potassium channel cloned from human heart. Circ Res. 71:1992;732-736.
59. + channel in ventricular muscle. A molecular correlate for the transient outward current. Circ Res. 79:1996;659-668.
60. Kong W., Po S., Yamagishi T., Ashen M.D., Stetten G., Tomaselli G.F. Isolation and characterization of the human gene encoding the transient outward potassium current: further diversity by alternative mRNA splicing. Am J Physiol. 275:1998;H1963-H1970.
61. + current in rat ventricular myocytes. Proc Natl Acad Sci (USA). 85:1988;8756-8760.
62. Fedida D., Shimoni Y., Giles W.R. A novel effect of norepinephrine on cardiac cells is mediated by alpha 1-adrenoceptors. Am J Physiol. 256:1989;H1500-H1504.
63. Braun A.P., Fedida D., Clark R.B., Giles W.R. Intracellular mechanisms for alpha 1-adrenergic regulation of the transient outward current in rabbit atrial myocytes. J Physiol (Lond). 431:1990;689-712.
64. Kääb S., Dixon J., Duc J., et al. Molecular basis of transient outward potassium current down-regulation in human heart failure: A decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation. 98:1998;1383-1393.
65. + channel isoforms in rat ventricle. J Physiol (Lond). 500:1997;65-73.
66. Winslow R, Rice J, Jafri S, Marban E, O'Rourke B. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure. II. Model studies. Circ Res 1999;84:in press.
67. + channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy. Circulation. 92:1995;164-174.
68. Furukawa T., Bassett A.L., Furukawa N., Kimura S., Myerburg R.J. The ionic mechanism of reperfusion-induced early afterdepolarizations in feline left ventricular hypertrophy. J Clin Invest. 91:1993;1521-1531.
69. K differs in feline left ventricular hypertrophy. Am J Physiol. 266:1994;H1121-H1131.
70. Choy A-M., Kuperschmidt S., Lang C.C., Pierson R.N., Roden D.M. Regional expression of HERG and KvLQT1 in heart failure. Circulation. 94:1996;1-164.
71. Koumi S.I., Martin R.L., Sato R. Alterations in ATP-sensitive potassium channel sensitivity to ATP in failing human hearts. Am J Physiol. 272:1997;H1656-H1665.
72. Hart G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc Res. 28:1994;933-946.
73. Aggarwal R., Boyden P.A. Altered pharmacologic responsiveness of reduced L-type calcium currents in myocytes surviving in the infarcted heart. J Cardiovasc Electrophysiol. 7:1996;20-35.
74. Keung E.C. Calcium current is increased in isolated adult myocytes from hypertrophied rat myocardium. Circ Res. 64:1989;753-763.
75. Scamps F., Mayoux E., Charlemagne D., Vassort G. Calcium current in single cells isolated from normal and hypertrophied rat heart. Effects of β-adrenergic stimulation. Circ Res. 67:1990;199-208.
76. Santos P.E., Barcellos L.C., Mill J.G., Masuda M.O. Ventricular action potential and L-type calcium channel in infarct-induced hypertrophy in rats. J Cardiovasc Electrophysiol. 6:1995;1004-1014.
77. Gomez A.M., Benitah J.P., Henzel D., Vinet A., Lorente P., Delgado C. Modulation of electrical heterogeneity by compensated hypertrophy in rat left ventricle. Am J Physiol. 1997;272.
78. Xiao Y.F., McArdle J.J. Elevated density and altered pharmacologic properties of myocardial calcium current of the spontaneously hypertensive rat. J Hypertens. 12:1994;783-790.
79. Kleiman R.B., Houser S.R. Calcium currents in normal and hypertrophied isolated feline ventricular myocytes. Am J Physiol. 255:1988;H1434-H1442.
80. Creazzo T.L. Reduced L-type calcium current in the embryonic chick heart with persistent truncus arteriosus. Circ Res. 66:1990;1491-1498.
81. Mukherjee R., Hewett K.W., Walker J.D., Basler C.G., Spinale F.G. Changes in L-type calcium channel abundance and function during the transition to pacing-induced congestive heart failure. Cardiovasc Res. 37:1998;432-444.
82. Momtaz A., Coulombe A., Richer P., Mercadier J.J., Coraboeuf E. Action potential and plateau ionic currents in moderately and severely DOCA-salt hypertrophied rat hearts. J Mol Cell Cardiol. 28:1996;2511-2522.
83. Bouron A., Potreau D., Raymond G. The L type calcium current in single hypertrophied cardiomyocytes isolated from the right ventricle of ferret heart. Cardiovasc Res. 26:1992;662-670.
84. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res. 73:1993;777-782.
85. Gidh-Jain M., Huang B., Jain P., Battula V., el-Sherif N. Reemergence of the fetal pattern of L-type calcium channel gene expression in non infarcted myocardium during left ventricular remodeling. Biochem Biophys Res Commun. 216:1995;892-897.
86. Ming Z., Nordin C., Siri F., Aronson R.S. Reduced calcium current density in single myocytes isolated from hypertrophied failing guinea pig hearts. J Mol Cell Cardiol. 26:1994;1133-1143.
87. 2+ channels to pressure overload: biochemical and physiological properties of the dihydropyridine receptors in normal and hypertrophied rat hearts. J Cardiovasc Pharmacol. 12:1988;390-396.
88. Finkel M.S., Marks E.S., Patterson R.E., Speir E.H., Steadman K.A., Keiser H.R. Correlation of changes in cardiac calcium channels with hemodynamics in Syrian hamster cardiomyopathy and heart failure. Life Sci. 41:1987;153-159.
89. Wagner J.A., Weisman H.F., Snowman A.M., Reynolds I.J., Weisfeldt M.L., Snyder S.H. Alterations in calcium antagonist receptors and sodium-calcium exchange in cardiomyopathic hamster tissues. Circ Res. 65:1989;205-214.
90. 2+ channels in experimental cardiac failure. Am J Physiol. 261:1991;H1979-H1987.
91. Dixon I.M., Lee S.L., Dhalla N.S. Nitrendipine binding in congestive heart failure due to myocardial infarction. Circ Res. 66:1990;782-788.
92. 2+-pump ATPase activity in tachycardia heart failure. Cell Calcium. 16:1994;349-356.
93. Vatner D.E., Sato N., Kiuchi K., Shannon R.P., Vatner S.F. Decrease in myocardial ryanodine receptors and altered excitation- contraction coupling early in the development of heart failure. Circulation. 90:1994;1423-1430.
94. Gengo P.J., Sabbah H.N., Steffen R.P., Sharpe J.K., Kono T., Stein P.D., Goldstein S. Myocardial β-adrenoceptor and voltage sensitive calcium channel changes in a canine model of chronic heart failure. J Mol Cell Cardiol. 24:1992;1361-1369.
95. Rasmussen R.P., Minobe W., Bristow M.R. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium. Biochem Pharmacol. 39:1990;691-696.
96. i-transients in single ventricular myocytes isolated from terminally failing human myocardium. Bas Res Cardiol. 87:1992;235-243.
97. Mewes T., Ravens U. L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium. J Mol Cell Cardiol. 26:1994;1307-1320.
98. Ouadid H., Albat B., Nargeot J. Calcium currents in diseased human cardiac cells. J Cardiovasc Pharmacol. 25:1995;282-291.
99. 2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest. 90:1992;927-935.
100. Gruver E.J., Morgan J.P., Stambler B.S., Gwathmey J.K. Uniformity of calcium channel number and isometric contraction in human right and left ventricular myocardium. Bas Res Cardiol. 89:1994;139-148.
101. Piot C., Lemaire S., Albat B., Seguin J., Nargeot J., Richard S. High frequency-induced upregulation of human cardiac calcium currents. Circulation. 93:1996;120-128.
102. Cavalie A., Pelzer D., Trautwein W. Fast and slow gating behaviour of single calcium channels in cardiac cells. Relation to activation and inactivation of calcium-channel current. Pflügers Arch. 406:1986;241-258.
103. Yue D.T., Backx P.H., Imredy J.P. Calcium-sensitive inactivation in the gating of single calcium channels. Science. 250:1990;1735-1738.
104. Schroeder F., Handrock R., Beuckelmann D.J., et al. Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation. 98:1998;969-976.
105. Hullin R.A., Asmus F., Berger H.J., Boekstegers P. Differential expression of the subunits of the cardiac L-type calcium channel in diastolic failure of the transplanted heart. Circulation. 96:1997;I-55.
106. Vassort G., Alvarez J. Cardiac T-type calcium current: pharmacology and roles in cardiac tissues. J Cardiovasc Electrophysiol. 5:1994;376-393.
107. Fares N., Gomez J.P., Potreau D. T-type calcium current is expressed in dedifferentiated adult rat ventricular cells in primary culture. C R Acad Sci III. 319:1996;569-576.
108. Chen C.C., Best P.M. Effects of IGF-1 on T-type calcium currents in cultured atrial myocytes. FASEB J. 10:1996;A310.
109. Xu X.P., Best P.M. Increase in T-type calcium current in atrial myocytes from adult rats with growth hormone-secreting tumors. Proc Natl Acad Sci (USA). 87:1990;4655-4659.
110. Beuckelmann D.J., Näbauer M., Erdmann E. Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol. 23:1991;929-937.
111. i handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J. 129:1995;684-689.
112. 2+ pump of sarcoplasmic reticulum. Nature. 342:1989;90-92.
113. Brillantes A.M., Allen P., Takahashi T., Izumo S., Marks A.R. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res. 71:1992;18-26.
114. Go L.O., Moschella M.C., Watras J., Handa K.K., Fyfe B.S., Marks A.R. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest. 95:1995;888-894.
115. Meyer M., Schillinger W., Pieske B., et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation. 92:1995;778-784.
116. Arai M., Alpert N.R., MacLennan D.H., Barton P., Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. 72:1993;463-469.
117. Mercadier J.J., Lompre A.M., Duc P., et al. Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest. 85:1990;305-309.
118. 2+ exchanger in end-stage human heart failure. Circ Res. 75:1994;443-453.
119. 2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation. 92:1995;3220-3228.
120. 2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J Mol Med. 74:1996;321-332.
121. Linck B., Boknik P., Eschenhagen T., et al. Messenger R.N.A. expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts. Cardiovasc Res. 31:1996;625-632.
122. Kuo T.H., Tsang W., Wang K.K., Carlock L. Simultaneous reduction of the sarcolemmal and SR calcium ATPase activities and gene expression in cardiomyopathic hamster. Biochim Biophys Acta. 1138:1992;343-349.
123. Feldman A.M., Weinberg E.O., Ray P.E., Lorell B.H. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 73:1993;184-192.
124. Zarain-Herzberg A., Afzal N., Elimban V., Dhalla N.S. Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem. 164:1996;285-290.
125. Hasenfuss G., Reinecke H., Studer R., Meyer M., Pieske B., Holtz J., Holubarsch C., Posival H., Just H., Drexler H. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res. 75:1994;434-442.
126. 2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ Res. 77:1995;759-764.
127. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res. 37:1998;279-289.
128. Movsesian M.A., Schwinger R.H. Calcium sequestration by the sarcoplasmic reticulum in heart failure. Cardiovasc Res. 37:1998;352-359.
129. Feldman A.M., Ray P.E., Silan C.M., Mercer J.A., Minobe W., Bristow M.R. Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation. 83:1991;1866-1872.
130. Movsesian M.A., Karimi M., Green K., Jones L.R. Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 90:1994;653-657.
131. Noma A., Tsuboi N. Dependence of junctional conductance on proton, calcium and magnesium ions in cardiac paired cells of guinea-pig. J Physiol (Lond). 382:1987;193-211.
132. 2+ exchanger in failing human myocardium. Circulation. 94:1996;992-1002.
133. 2+ exchange activity in patients with end-stage heart failure. Cardiovasc Res. 31:1996;48-54.
134. 2+ exchange (NCX) current density is unchanged in heart failure despite an increase in NCX protein. Circulation. 98:1998;I-679.
135. Gwathmey J.K., Slawsky M.T., Hajjar R.J., Briggs G.M., Morgan J.P. Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest. 85:1990;1599-1613.
136. Hasenfuss G., Reinecke H., Studer R., et al. Calcium cycling proteins and force-frequency relationship in heart failure. Basic Res Cardiol. 91:1996;17-22.
137. 2+ handling. J Clin Invest. 98:1996;764-776.
138. Mattiello J.A., Margulies K.B., Jeevanandam V., Houser S.R. Contribution of reverse-mode sodium-calcium exchange to contractions in failing human left ventricular myocytes. Cardiovasc Res. 37:1998;424-431.
139. Yanagihara K., Irisawa H. Inward current activated during hyperpolarization in the rabbit sinoatrial node cell. Pflügers Arch. 385:1980;11-19.
140. Brown H.F., DiFrancesco D., Noble S.J. How does adrenaline accelerate the heart? Nature. 280:1979;235-236.
141. Brown H., Difrancesco D. Voltage-clamp investigations of membrane currents underlying pace-maker activity in rabbit sino-atrial node. J Physiol (Lond). 308:1980;331-351.
142. Yu H., Chang F., Cohen I.S. Pacemaker current exists in ventricular myocytes. Circ Res. 72:1993;232-236.
143. Ranjan R., Chiamvimonvat N., Thakor N.V., Tomaselli G.F., Marban E. Mechanism of anode break stimulation in the heart. Biophys J. 74:1998;1850-1863.
144. f, in ventricular myocytes from human failing heart. Circulation. 95:1997;568-571.
145. Hoppe U.C., Jansen E., Sudkamp M., Beuckelmann D.J. Hyperpolarization-activated inward current in ventricular myocytes from normal and failing human hearts. Circulation. 97:1998;55-65.
146. Ludwig A., Zong X., Jeglitsch M., Hofmann F., Biel M. A family of hyperpolarization-activated mammalian cation channels. Nature. 393:1998;587-591.
147. f in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation. 94:1996;1674-1681.
148. Dhalla N.S., Dixon I.M., Rupp H., Barwinsky J. Experimental congestive heart failure due to myocardial infarction: sarcolemmal receptors and cation transporters. Basic Res Cardiol. 86:1991;13-23.
149. Houser S.R., Freeman A.R., Jaeger J.M., Breisch E.A., Coulson R.L., Carey R., Spann J.F. Resting potential changes associated with Na-K pump in failing heart muscle. Am J Physiol. 240:1981;H168-H176.
150. +-ATPase concentration in rodent and human heart and skeletal muscle: apparent relation to muscle performance. Cardiovasc Res. 22:1988;95-100.
151. Zahler R., Gilmore-Hebert M., Sun W., Benz E.J. Na, K-ATPase isoform gene expression in normal and hypertrophied dog heart. Basic Res Cardiol. 91:1996;256-266.
152. +-ATPase in tachycardia induced cardiomyopathy. J Mol Cell Cardiol. 24:1992;277-294.
153. Bristow M.R., Ginsburg R., Minobe W., et al. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. New Engl J Med. 307:1982;205-211.
154. Bristow M.R. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol. 22:1993;61A-71A.
155. Bohm M., Flesch M., Schnabel P. Beta-adrenergic signal transduction in the failing and hypertrophied myocardium. J Mol Med. 75:1997;842-848.
156. 2-adrenergic modulation of cardiac excitation-contraction coupling. Am J Physiol. 273:1997;H1611-H1618.
157. Hartzell H.C., Duchatelle-Gourdon I. Regulation of the cardiac delayed rectifier K current by neurotransmitters and magnesium. Cardiovasc Drugs Ther. 7:(3):1993;547-554.
158. Fedida D., Braun A.P., Giles W.R. α-1-Adrenoceptors in myocardium: functional aspects and transmembrane signaling mechanisms. Physiol Rev. 73:1993;469-487.
159. Marban E. Molecular approaches to arrhythmogenesis. Chien K. Molecular basis of heart disease. 1998;W.B. Saunders, New York.
160. Aronson R.S., Ming Z. Cellular mechanisms of arrhythmias in hypertrophied and failing myocardium. Circulation. 87:1993;76-83.
161. Li H.G., Jones D.L., Yee R., Klein G.J. Arrhythmogenic effects of catecholamines are decreased in heart failure induced by rapid pacing in dogs. Am J Physiol. 265:1993;H1654-H1662.
162. Li H.G., Jones L., Yee R., Klein G.J. Electrophysiologic substrate associated with pacing-induced heart failure in dogs: potential value of programmed stimulation in predicting sudden death. J Am Coll Cardiol. 19:1992;444-449.
163. Wang Z., Taylor L.K., Denney W.D., Hansen D.E. Initiation of ventricular extrasystoles by myocardial stretch in chronically dilated and failing canine left ventricle. Circulation. 90:1994;2022-2031.
164. Nuss H.B., Kääb S., Kass D.A., Tomaselli G.F., Marban E. Increased susceptibility to arrhythmogenic early after depolarization and oscillatory prepotentials in failing canine ventricular myocytes. Circulation. 92:1995;I-434.
165. Aronson R.S. Afterpotentials and triggered activity in hypertrophied myocardium from rats with renal hypertension. Circ Res. 48:1981;720-727.
166. Ben-David J., Zipes D.P., Ayers G.M., Pride H.P. Canine left ventricular hypertrophy predisposes to ventricular tachycardia induction by phase 2 early afterdepolarizations after administration of BAY K 8644. J Am Coll Cardiol. 20:1992;1576-1584.
167. Sicouri S., Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res. 68:1991;1729-1741.
168. i on nexal membrane resistance. Pflügers Arch. 409:1987;394-402.
169. Peters N.S. New insights into myocardial arrhythmogenesis: distribution of gap- junctional coupling in normal, ischaemic and hypertrophied human hearts. Clin Sci (Colch). 90:1996;447-452.
170. Severs N.J. Gap junction alterations in the failing heart. Eur Heart J. 15:(D):1994;53-57.
171. Spach M.S., Boineau J.P. Microfibrosis produces electrical load variations due to loss of side- to-side cell connections: a major mechanism of structural heart disease arrhythmias. Pacing Clin Electrophysiol. 20:1997;397-413.